Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60
Egeberg, Alexander, Hawkes, Jason E., Somani, Najwa, Burge, Russel, See, Kyoungah, Gallo, Gaia, McKean-Matthews, Missy, Gooderham, Melinda, Han, George, Armstrong, April
Published in Dermatology and therapy (01.04.2024)
Published in Dermatology and therapy (01.04.2024)
Get full text
Journal Article
41824 Palmoplantar psoriasis complete clearance is achieved rapidly and sustained with ixekizumab treatment in adult and pediatric patients with moderate-to-severe plaque psoriasis
Menter, Martin Alan, Armstrong, April, Kircik, Leon, Gniadecki, Robert, Garrelts, Alyssa, See, Kyoungah, McKean-Matthews, Missy, Bagel, Jerry
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
26032 Sustained and rapid improvements in patient reported outcomes for moderate-to-severe psoriasis patients with moderate and high BSA treated with ixekizumab: Side-by-side results from UNCOVER-3 and IXORA-S
Bagel, Jerry, Gottlieb, Alice B., Burge, Russel, See, Kyoungah, Garrelts, Alyssa, McKean-Matthews, Missy, Papp, Kim
Published in Journal of the American Academy of Dermatology (01.09.2021)
Published in Journal of the American Academy of Dermatology (01.09.2021)
Get full text
Journal Article
51582 Simultaneous Genital Skin Clearance and Patient Reported Outcome Responses at Weeks 24 and 52 in Patients with Moderate-to-Severe Genital Psoriasis Treated with Ixekizumab: an analysis of the Phase 3 Clinical Trial IXORA-Q
Cather, Jennifer Clay, Soung, Jennifer, Yosipovitch, Gil, Ryan, Caitriona, El Rayes, Mohamed, Konicek, Bruce W., Edson-Heredia, Emily, See, Kyoungah, Mckean-Matthews, Missy, Gooderham, Melinda
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
13876 Achieving a PASI 50 at 2 weeks was associated with better long-term clinical outcomes and low discontinuation: A subgroup analysis of a phase 3 trial of ixekizumab and etanercept in moderate to severe psoriasis
Rosmarin, David, Shrom, David, Burge, Russel, See, Kyoungah, McKean-Matthews, Missy, Ridenour, Terri
Published in Journal of the American Academy of Dermatology (01.12.2020)
Published in Journal of the American Academy of Dermatology (01.12.2020)
Get full text
Journal Article
41602 Achievement of National Psoriasis Foundation (NPF) treatment targets and acceptable responses among patients with psoriasis treated with ixekizumab versus other biologics in head-to- head clinical trials
Armstrong, April, Blauvelt, Andrew, Papp, Kim A., Green, Lawrence J., Feely, Meghan, Malatestinic, William N., See, Kyoungah, McKean-Matthews, Missy, Strober, Bruce E.
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
43113 Ixekizumab improves fatigue, an important patient-reported outcome in psoriasis
Merola, Joseph, Gladman, Dafna, Tahir, Hasan, Boehncke, Wolf-Henning, Garrelts, Alyssa, See, Kyoungah, McKean-Matthews, Missy, Feely, Meghan, Bolce, Rebecca, Birt, Julie, Strand, Vibeke
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
24899 Ixekizumab sustains high efficacy and a favorable safety profile in burdensome areas in patients with moderate-to-severe psoriasis: 5-year results from UNCOVER-2
Papp, Kim, Blauvelt, Andrew, Puig, Luis, Elmaraghy, Hany, See, Kyoungah, McKean-Matthews, Missy, Crane, Heidi, Garrelts, Alyssa, Leonardi, Craig
Published in Journal of the American Academy of Dermatology (01.09.2021)
Published in Journal of the American Academy of Dermatology (01.09.2021)
Get full text
Journal Article
25748 Ixekizumab sustained complete clearance, itch resolution, and improved quality of life for moderate-to-severe psoriasis patients who achieved rapid, high skin clearance
Rosmarin, David, Gooderham, Melinda, Ferris, Laura, See, Kyoungah, Wolf, Eric, Burge, Russel, McKean-Matthews, Missy, Reich, Kristian
Published in Journal of the American Academy of Dermatology (01.09.2021)
Published in Journal of the American Academy of Dermatology (01.09.2021)
Get full text
Journal Article
Put Thinking to the Test
Conrad, Lori L, Matthews, Missy, Zimmerman, Cheryl, Allen, Patrick A
Published in Stenhouse Publishers (2008)
Published in Stenhouse Publishers (2008)
Get more information
Book
Early Response is Associated With Stable Long-Term Response in Psoriasis Patients Receiving Ixekizumab or Ustekinumab
Augustin, Mathias, Gallo, Gaia, See, Kyoungah, McKean-Matthews, Missy, Burge, Russel, Gooderham, Melinda, Reich, Kristian
Published in Journal of drugs in dermatology (01.02.2022)
Published in Journal of drugs in dermatology (01.02.2022)
Get more information
Journal Article
14157 Speed of improvement in genital psoriasis, genital itch, sexual impact, and health-related quality of life in patients with moderate to severe genital psoriasis treated with ixekizumab
Merola, Joseph F., Guenther, Lyn, Foley, Peter, Burge, Russel, See, Kyoungah, McKean-Matthews, Missy, Gallo, Gaia, Ryan, Caitriona
Published in Journal of the American Academy of Dermatology (01.12.2020)
Published in Journal of the American Academy of Dermatology (01.12.2020)
Get full text
Journal Article
Efficacy and safety of ixekizumab over 4 years of open-label treatment in a phase 2 study in chronic plaque psoriasis
Zachariae, Claus, Gordon, Kenneth, Kimball, Alexandra B., Lebwohl, Mark, Blauvelt, Andrew, Leonardi, Craig, Braun, Daniel, McKean-Matthews, Missy, Burge, Russel, Cameron, Gregory
Published in Journal of the American Academy of Dermatology (01.08.2018)
Published in Journal of the American Academy of Dermatology (01.08.2018)
Get full text
Journal Article
Normal transcutaneous oxygen pressure in skin after radiation therapy for cancer
Rudolph, Ross, Tripuraneni, Prabhakar, Koziol, James A., McKean‐Matthews, Missy, Frutos, Adriana
Published in Cancer (01.12.1994)
Published in Cancer (01.12.1994)
Get full text
Journal Article
Benefits Over Five Years of Ixekizumab Treatment in Patients With Psoriasis Involving Challenging Body Areas
Gottlieb, Alice B, Armstrong, April, Blauvelt, Andrew, Griffiths, Christopher E M, Pinter, Andreas, Gooderham, Melinda, Lomaga, Mark, Burge, Russel T, Konicek, Bruce W, McDonald, Meghan Feely, See, Kyoungah, McKean-Matthews, Missy, Mabuchi, Tomotaka
Published in Journal of drugs in dermatology (01.08.2024)
Published in Journal of drugs in dermatology (01.08.2024)
Get more information
Journal Article
Psoriasis Severity Assessment Combining Physician and Patient Reported Outcomes: The Optimal Psoriasis Assessment Tool
Leonardi, Craig, See, Kyoungah, Gallo, Gaia, McKean-Matthews, Missy, Zhang, Ying, Goldblum, Orin, Mallbris, Lotus, Burge, Russel
Published in Dermatology and therapy (01.08.2021)
Published in Dermatology and therapy (01.08.2021)
Get full text
Journal Article
Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies
Gooderham, Melinda J, Elewski, Boni, Augustin, Matthias, Iversen, Lars, Torii, Hideshi, Burge, Russel, See, Kyoungah, Gallo, Gaia, Eastman, William J, McKean-Matthews, Missy, Foley, Peter
Published in Journal of drugs in dermatology (01.04.2021)
Published in Journal of drugs in dermatology (01.04.2021)
Get more information
Journal Article
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Elewski, Boni E., Blauvelt, Andrew, Gallo, Gaia, Wolf, Eric, McKean-Matthews, Missy, Burge, Russel, Merola, Joseph F., Gottlieb, Alice B., Guenther, Lyn C.
Published in Dermatology and therapy (01.04.2022)
Published in Dermatology and therapy (01.04.2022)
Get full text
Journal Article
Dynamic Visual Representation of Clinical Efficacy of Ixekizumab in Psoriasis
Hawkes, Jason E., See, Kyoungah, Burge, Russel, Strakbein, Stephanie, McKean-Matthews, Missy, Saure, Daniel, Gooderham, Melinda, Leonardi, Craig
Published in Dermatology and therapy (01.08.2021)
Published in Dermatology and therapy (01.08.2021)
Get full text
Journal Article
Efficacy, Health-Related Outcomes, and Safety of Ixekizumamb for up to Five Years of Open-Label Treatment in a Phase 2 Study in Chronic Plaque Psoriasis
Blauvelt, Andrew, Leonardi, Craig, Zachariae, Claus, Burge, Russel, Ridenour, Terri, McKean-Matthews, Missy, Garces, Sandra, Cameron, Gregory
Published in Skin (Milwood, N.Y.) (27.10.2017)
Published in Skin (Milwood, N.Y.) (27.10.2017)
Get full text
Journal Article